<DOC>
	<DOCNO>NCT00099086</DOCNO>
	<brief_summary>This phase I trial study side effect best dose docetaxel give radiation therapy hormone therapy patient locally advanced prostate cancer .</brief_summary>
	<brief_title>Docetaxel , Radiation Therapy , Hormone Therapy Treating Patients With Locally Advanced Prostate Cancer</brief_title>
	<detailed_description>Drugs use chemotherapy , docetaxel , work different way stop growth tumor cell , either kill cell stop divide . Radiation therapy use high energy x-ray kill tumor cell . Docetaxel may also make tumor cell sensitive radiation therapy . Androgens cause growth prostate cancer cell . Drugs , leuprolide , goserelin , bicalutamide , may stop adrenal gland make androgen . Giving chemotherapy radiation therapy hormone therapy may kill tumor cell .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>1 . Histologically confirm adenocarcinoma prostate one prognostic factor specify protocol . No pelvic lymph node disease would necessitate pelvic radiotherapy . No radiologic evidence metastatic disease bone scan CT scan MRI abdomen pelvis 2 . No prior radiation therapy , chemotherapy , immunotherapy alternative therapy prostate cancer . Greater 4 week since major surgery . 3 . Performance status 02 4 . Must meet criterion acceptable lab value outline protocol . 5 . Peripheral neuropathy must great equal 1 6 . Men childbearing potential must willing consent use effective contraception treatment least 3 month thereafter . 1 . No history severe hypersensitivity reaction docetaxel drug formulate Polysorbate 80</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>